Seranova is an early-stage company poised to create the next generation of therapeutics. Our proprietary REAP technology enables the dissection of the immune interactions that drive health and disease, while our serological atlas and analytics platform will offer an unprecedented level of insight to help us achieve our mission. Founded in 2020 by Yale professor and serial academic entrepreneur Aaron Ring, Seranova is headquartered in South San Francisco and funded by Foresite Capital Management. 



Join TechBio Companies Driving Patient Impact